Chamath Palihapitiya

It's going to be glorious to watch because we're all going to laugh and realize that was stupid and should never have happened in the first place.

Yeah.

I mean, there is a chance that this improves to the point, passes trial of disillusionment, and becomes super productive.

And you'll be able to get an agent to do reasonable things without deleting your data set.

But we have a way to go.

Here is your, you know, this is the tech adoption chart, basically.

You've got a technology that gets triggered.

You have this peak of inflated expectations.

You go into the trial of disillusionment, and then the slope of enlightenment, and eventually it becomes...

de rigueur and it's an opportunity.

Hey, Friedberg, you have become Reddit True Tide Curious.

And also, you.

Tell me about RETA, Friedberg, because I want it.

And I need you to tell Nat that it's okay for me to take it.

I have a friend who has some advice as well.

Over to you, Friedberg.

The coverage is coming out of this phase three clinical trial data release that Lily put out last month.

So everyone's going...

crazy over the data, which continues to show pretty amazing results.

So unlike Terzepatide, which is kind of Lilly's main